The UDoTest in-home delivery platform was designed to close screening gaps and to serve your patients with a unique at-home screening experience, that's supported by labs and physicians and focuses on high cost, high-risk diseases.

If closing screening gaps, improving your patient engagement, and improving HEDIS quality is a need for you, then our UDoTest platform is your solution. UDoTest's at-home delivery platform was designed to close screening gaps, and to activate a unique at-home screening experience for your patients. Our sophisticated platform and service was designed specifically for providers, and works with their laboratories and physicians, while focussing on high cost, high-risk diseases. We're currently working with leading providers and health plans across the country on their cancer, diabetes screening and quality gaps to name a few.

Lazarus CDS leverages Artificial Intelligence to improve early cancer detection by turning a primary care doctor into a specialist for 5 minutes. For diseases like cervical cancer, this is as simple as a simple prompt that alerts physicians of high-risk patients, enabling them to make better clinical decisions. In skin cancer, we turn any mobile device into an AI-powered dermascope, automatically classifying risk based on a whole host of factors. Best of all, it's fully explainable. No black boxes, just real results.

Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians.